Growth suppression of glioma cells by PTEN requires a functional phosphatase catalytic domain
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
Deletions of all or part of chromosome 10 are the most common genetic alterations in high-grade gliomas. The PTEN gene (also called MMAC1 and TEP1 ) maps to chromosome region 10q23 and has been implicated as a target of alteration in gliomas and also in other cancers such as those of the breast, prostate, and kidney. Here we sought to provide a functional test of its candidacy as a growth suppressor in glioma cells. We used a combination of Northern blot analysis, protein truncation assays, and sequence analysis to determine the types and frequency of PTEN mutations in glioma cell lines so that we could define appropriate recipients to assess the growth suppressive function of PTEN by gene transfer. Introduction of wild-type PTEN into glioma cells containing endogenous mutant alleles caused growth suppression, but was without effect in cells containing endogenous wild-type PTEN . The ectopic expression of PTEN alleles, which carried mutations found in primary tumors and have been shown or are expected to inactivate its phosphatase activity, caused little growth suppression. These data strongly suggest that PTEN is a protein phosphatase that exhibits functional and specific growth-suppressing activity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S. I., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., et al. (1997) · Science · doi:10.1126/science.275.5308.1943 · Cited by 4,785
Steck, P. A., Pershouse, M. A., Jasser, S. A., Yung, W. K. A., Lin, H., Ligon, A. H., Langford, L. A., Baumgard, M. L., Hattier, T., Davis, T., et al. (1997) · Nature Genetics · doi:10.1038/ng0497-356 · Cited by 2,741
Self-citationMorgenstern, J. P., & Land, H. (1990) · Nucleic Acids Research · doi:10.1093/nar/18.12.3587 · Cited by 2,101
Liaw, D., Marsh, D. J., Li, J., Dahia, P. L. M., Wang, S. I., Zheng, Z., Bose, S., Call, K. M., Tsou, H. C., Peacoke, M., et al. (1997) · Nature Genetics · doi:10.1038/ng0597-64 · Cited by 2,091
Krawczak, M., Reiss, J., & Cooper, D. (1992) · Human Genetics · doi:10.1007/bf00210743 · Cited by 1,324
Li, D., & Sun, H. (1997) · PubMed · Cited by 866
P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase
Myers, M. P., Stolarov, J. P., Eng, C., Li, J., Wang, S. I., Wigler, M. H., Parsons, R., & Tonks, N. K. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.17.9052 · Cited by 775
Germline mutations in PTEN are present in Bannayan-Zonana syndrome
Marsh, D. J., Dahia, P. L. M., Zheng, Z., Liaw, D., Parsons, R., Gorlin, R. J., & Eng, C. (1997) · Nature Genetics · doi:10.1038/ng0897-333 · Cited by 655
Clonal genomic alterations in glioma malignancy stages.
Cd, J., Carlbom, E., Dumanski, J. P., Hansen, M., Nordenskjöld, M., Collins, V. P., & Cavenee, W. K. (1988) · PubMed · Cited by 512
Self-citationGermline mutations in the PTEN/MMAC1 gene in patients with Cowden disease
Nelen, M. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.8.1383 · Cited by 464
CDKN2/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated.
Ueki, K., Ono, Y., Henson, J. W., Efird, J. T., von Deimling, A., & Louis, D. N. (1996) · PubMed · Cited by 404
Crystal structure of Yersinia protein tyrosine phosphatase at 2.5 Å and the complex with tungstate
Stuckey, J. A., Schubert, H. L., Fauman, E. B., Zhang, Z.-Y., Dixon, J. E., & Saper, M. A. (1994) · Nature · doi:10.1038/370571a0 · Cited by 391
Rapid, reversible staining of northern blots prior to hybridization.
Herrin, D. L., & Schmidt, G. W. (1988) · PubMed · Cited by 356
Crystal Structure of the Dual Specificity Protein Phosphatase VHR
Yuvaniyama, J., Denu, J. M., Dixon, J. E., & Saper, M. A. (1996) · Science · doi:10.1126/science.272.5266.1328 · Cited by 343
Specific chromosomal abnormalities in malignant human gliomas.
Sh, B., Mark, J., Burger, P. C., Ms, M., Bullard, D. E., Lh, M., & Bigner, D. D. (1988) · PubMed · Cited by 340
Analysis of the p53 gene and its expression in human glioblastoma cells.
Meir, E. G. V., Kikuchi, T., Tada, M., Li, H., Diserens, A., Wojcik, B. E., Huang, H., Friedmann, T., de Tribolet, N., & Cavenee, W. K. (1994) · PubMed · Cited by 327
Self-citationRapid detection of BRCA1 mutations by the protein truncation test
Hogervorst, F. B. L., Cornelis, R. S., Bout, M., Vliet, M. V., Oosterwijk, J. C., Olmer, R., Bakker, B., Klijn, J. G. M., Vasen, H. F. A., Meijers-Heijboer, H., et al. (1995) · Nature Genetics · doi:10.1038/ng0695-208 · Cited by 312
Protein truncation test (PTT) for rapid detection of translation-terminating mutations
Roest, P. A. M., Roberts, R. G., Sugino, S., van Ommen, G.-J. B., & den Dunnen, J. T. (1993) · Human Molecular Genetics · doi:10.1093/hmg/2.10.1719 · Cited by 299
Molecular pathways in the formation of gliomas
von Deimling, A., Louis, D. N., & Wiestler, O. D. (1995) · Glia · doi:10.1002/glia.440150312 · Cited by 245
CDK4 amplification is an alternative mechanism to p16 gene homozygous deletion in glioma cell lines.
He, J., Allen, J. R., Collins, V. P., Allalunis‐Turner, M. J., Godbout, R., Day, R. S., & James, C. D. (1994) · PubMed · Cited by 238
van der Luijt, R., Khan, P. M., Vasen, H., van Leeuwen, C., Tops, C., Roest, P., den Dunnen, J., & Fodde, R. (1994) · Genomics · doi:10.1006/geno.1994.1119 · Cited by 212
He, J., Olson, J. J., & James, C. D. (1995) · PubMed · Cited by 188
A tiger behind many doors: multiple genetic pathways to malignant glioma
Louis, D. N., & Gusella, J. F. (1995) · Trends in Genetics · doi:10.1016/s0168-9525(00)89125-8 · Cited by 185
Chromosome 10 deletion mapping in human gliomas: a common deletion region in 10q25.
Rasheed, B., McLendon, R. E., Friedman, H. S., Friedman, A. H., Fuchs, H. E., Bigner, D. D., & Bigner, S. H. (1995) · PubMed · Cited by 183
Interleukin-8 is produced in neoplastic and infectious diseases of the human central nervous system.
Meir, E. G. V., Ceska, M., Effenberger, F., Walz, A., Grouzmann, E., Desbaillets, I., Frei, K., Fontana, A., & de Tribolet, N. (1992) · PubMed · Cited by 151
Ataxia-telangiectasia: mutations in ATM cDNA detected by protein-truncation screening.
Telatar, M., Wang, Z., Udar, N., Liang, T., Bernatowska, E. A., Lavin, M. F., Shiloh, Y., CONCANNON, P. J., Good, R. A., & Gatti, R. A. (1996) · PubMed Central · Cited by 143
Homozygous deletion of the MTS1/p16 and MTS2/p15 genes and amplification of the CDK4 gene in glioma.
Sonoda, Y., Yoshimoto, T., & Sekiya, T. (1995) · PubMed · Cited by 61
Regulation of the Epstein-Barr virus DNA polymerase gene
Furnari, F. B., Adams, M. D., & Pagano, J. S. (1992) · Journal of Virology · doi:10.1128/jvi.66.5.2837-2845.1992 · Cited by 41
Self-citationMolecular genetics of human glioma
Westermark, B., & Nistér, M. (1995) · Current Opinion in Oncology · doi:10.1097/00001622-199505000-00005 · Cited by 41
Molecular genetics and molecular biology advances in brain tumors
James, C. D., & Olson, J. J. (1996) · Current Opinion in Oncology · doi:10.1097/00001622-199605000-00004 · Cited by 29
Carlsson, J., & Acker, H. (1985) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(85)90185-3 · Cited by 26
Petronio, J. A., He, J., Fults, D. W., Pedone, C. A., James, C. D., & Allen, J. (1996) · Journal of neurosurgery · doi:10.3171/jns.1996.84.6.1020 · Cited by 14
Cited by
Maehama, T., & Dixon, J. E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.22.13375 · Cited by 3,104
Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN
Stambolic, V., Suzuki, A., de la Pompa, J. L., Brothers, G. M., Mirtsos, C., Sasaki, T., Ruland, J., Penninger, J. M., Siderovski, D. P., & Mak, T. W. (1998) · Cell · doi:10.1016/s0092-8674(00)81780-8 · Cited by 2,551
Cantley, L. C., & Neel, B. G. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.8.4240 · Cited by 2,006
Synthesis and Function of 3-Phosphorylated Inositol Lipids
Vanhaesebroeck, B., Leevers, S. J., Ahmadi, K., Timms, J., Katso, R., Driscoll, P. C., Woscholski, R., Parker, P. J., & Waterfield, M. D. (2001) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.70.1.535 · Cited by 1,535
Pten is essential for embryonic development and tumour suppression
Cristofano, A. D., Pesce, B., Cordon-Cardo, C., & Pandolfi, P. P. (1998) · Nature Genetics · doi:10.1038/1235 · Cited by 1,516
Metadata
- Authors
- Furnari, F. B., Lin, H., Huang, H.-J. S., & Cavenee, W. K.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1997-11-11
- Volume
- 94
- Issue
- 23
- Pages
- 12479-12484
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2019017173
- Cited by
- 434
- References
- 32
- FWCI
- 12.04
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.